Bioanalytical Systems, Inc.

4Q Revenues: $5.2 million (+4%)

4Q Loss: $2.0 million (loss of $721,000 4Q15)

FY Revenues:$20.4 million (-10%)

FY Loss: $3.2 million (earnings were $1.1 million FY15)

Comments: Service revenue for the year was negatively impacted by fewer bioequivalence studies as well as fewer samples received and analyzed, as well as an increase in method development and validation projects, which generate lower revenue but involve more dedicated resources.